COVID-19 ‘fastest point-of-care test’ from Abbott: FDA issues EUA

Abbott announced Friday that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes. The test will run on the company's ID NOWa platform, providing ["]

The post COVID-19 'fastest point-of-care test' from Abbott: FDA issues EUA appeared first on Outbreak News Today.